Clinical Trial Update: A Study of Mircera in Anemic Patients With Multiple Myeloma [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial evaluated Mircera for treating anemia in patients with multiple myeloma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Multiple Myeloma

Drugs mentioned

• MIRCERA (METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Anemia | Phase 1, Phase 2 | Status: COMPLETED